CVC & GBL / Recordati: A Higher Dose for the Holdouts
CVC/GBL have raised the offer price to €53, but limited minority participation leaves the revised offer facing another test.
95 Views
Recordati (REC IM): Synthetic Expert Call Transcript (16 Sep 2026)
The CVC-GBL "Delisting Merger" provides an absolute mechanical bottleneck for minority holdouts. If private equity sponsors fail to reach the 90%...
86 Views
Recordati: Minority Opposition Puts €51.29 Under Pressure
Minority shareholders are refusing €51.29, but CVC/GBL may not need 90% to delist Recordati. We examine the threshold arithmetic, merger route and...
92 Views
Primer: Recordati (REC IM) - Aug 2026
Recordati is strategically positioned for growth, driven by its high-margin, rapidly expanding Rare Diseases business, which now accounts for...
97 Views
Recordati: Control Was Never the Question
CVC and GBL formalised their Recordati take-private at €51.29/share. With financing secured and only ~37% of free float needed, investors are now...
105 Views